These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18400717)

  • 41. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.
    Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M
    Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth].
    Koirala K; Wan YL; Liu YC; Wang X; Cui W; Wang CL; Chen HN; Wang HY; Zhu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):385-8. PubMed ID: 16892143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Peroxisome proliferator-activated receptor activator troglitazone inhibits angiotensin II-stimulated secretion of vasoactive factors by endothelial cells].
    Li YQ; Niu XL; Wang CX; Wei J; Wang SJ; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1030-3. PubMed ID: 17666345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
    Zhou YB; Zhang J; Peng DQ; Chang JR; Cai Y; Yu YR; Jia MZ; Wu W; Guan YF; Tang CS; Qi YF
    Cell Biochem Biophys; 2013 Jul; 66(3):421-9. PubMed ID: 23274912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
    Keshamouni VG; Arenberg DA; Reddy RC; Newstead MJ; Anthwal S; Standiford TJ
    Neoplasia; 2005 Mar; 7(3):294-301. PubMed ID: 15799829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y; Hou G; Li ER; Wang QY; Kang J
    Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
    Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
    Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of peroxisome proliferator-activated receptor-gamma and retinoid X receptor inhibits aromatase transcription via nuclear factor-kappaB.
    Fan W; Yanase T; Morinaga H; Mu YM; Nomura M; Okabe T; Goto K; Harada N; Nawata H
    Endocrinology; 2005 Jan; 146(1):85-92. PubMed ID: 15459115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells.
    Zhu M; Flynt L; Ghosh S; Mellema M; Banerjee A; Williams E; Panettieri RA; Shore SA
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):111-9. PubMed ID: 20870897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
    Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PPAR gamma ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2.
    Klopotek A; Hirche F; Eder K
    Exp Biol Med (Maywood); 2006 Sep; 231(8):1365-72. PubMed ID: 16946405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.
    Saubermann LJ; Nakajima A; Wada K; Zhao S; Terauchi Y; Kadowaki T; Aburatani H; Matsuhashi N; Nagai R; Blumberg RS
    Inflamm Bowel Dis; 2002 Sep; 8(5):330-9. PubMed ID: 12479648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. L-165,041, troglitazone and their combination treatment to attenuate high glucose-induced receptor for advanced glycation end products (RAGE) expression.
    Liang YJ; Jian JH; Chen CY; Hsu CY; Shih CY; Leu JG
    Eur J Pharmacol; 2013 Sep; 715(1-3):33-8. PubMed ID: 23831394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
    Akinyeke TO; Stewart LV
    Cancer Biol Ther; 2011 Jun; 11(12):1046-58. PubMed ID: 21525782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiologic and pharmacologic modulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta-cells by peroxisome proliferator-activated receptor (PPAR)-gamma signaling: possible mechanism for the GIP resistance in type 2 diabetes.
    Gupta D; Peshavaria M; Monga N; Jetton TL; Leahy JL
    Diabetes; 2010 Jun; 59(6):1445-50. PubMed ID: 20332343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells.
    Tomita H; Osanai T; Toki T; Sasaki S; Maeda N; Murakami R; Magota K; Yasujima M; Okumura K
    Cardiovasc Res; 2005 Jul; 67(1):134-41. PubMed ID: 15949477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901/VCR cells by PPARgamma activation by troglitazone.
    Chen Q; Zhou J; Jiang C; Chen J
    J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):326-31. PubMed ID: 20556576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.